Tetrabenazine: Phase III data

In the 12-week, double-blind Phase III TETRA-HD trial in 84 patients, tetrabenazine significantly reduced chorea score

Read the full 162 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE